Clinical Trials Logo

Filter by:
NCT ID: NCT01534403 Completed - Clinical trials for Systemic Lupus Erythematosus

Open Label Extension Study of Epratuzumab in Japanese Systemic Lupus Erythematosus (SLE) Subjects

Start date: January 2012
Phase: Phase 2
Study type: Interventional

The study is an open-labeled extension study to continue to assess the safety and tolerability of Epratuzumab in moderate to severe SLE subjects who have previously participated in SL0026 [NCT01449071] phase I/II trial.

NCT ID: NCT01533532 Completed - Endometriosis Clinical Trials

A Randomized, Placebo-controlled, Double-blind Study of KLH-2109 in Patients With Endometriosis (2)

Start date: n/a
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of KLH-2109 in patients with endometriosis.

NCT ID: NCT01533064 Completed - Mood Disorders Clinical Trials

Response of Psychiatric Outpatients to the Great East Japan Earthquake

Start date: March 2011
Phase: N/A
Study type: Observational

Objective: Reports have described how hospitalized psychiatric patients respond to disasters; however, few reports have described the response to disaster among psychiatric outpatients, who have relatively mild disease in comparison with hospitalized, severely ill psychiatric patients. Here the investigators have analyzed the response to disaster among this under-studied population. Method: The Great East Japan Earthquake on March 11, 2011, was a catastrophic disaster. The investigators studied psychiatric change among a population of psychiatric outpatients in Tochigi prefecture, located ~160 km (~100 miles) southeast of the Fukushima nuclear power plant, in an area that suffered moderate damage from the earthquake. A total of 328 psychiatric outpatients were enrolled and were grouped into the diagnostic categories F2 (schizophrenic, schizotypal, and delusional disorders), F3 (affective disorders), and F4 (neurotic, stress-related, and somatoform disorders). All diagnoses were made using International Classification of Diseases (ICD) 10 criteria. Changes in symptoms were measured as a change in psychotropic medication after the disaster.

NCT ID: NCT01532570 Completed - Behcet's Disease Clinical Trials

Clinical Study of TA-650 in Patients With Behcet's Disease (BD) With Special Lesions

Start date: January 2012
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy, safety, and pharmacokinetics of TA-650 in patients with Behcet's disease ( BD ) with special lesions after the administration of TA-650 at a dosage of 5 mg/kg in weeks 0, 2, and 6, then every 8 weeks after week 14 up to week 46.

NCT ID: NCT01529619 Completed - Alzheimer's Disease Clinical Trials

Efficacy, Safety and Tolerability of Rivastigmine Patch in Patients With Mild to Moderate Alzheimer's Disease Switched From Cholinesterase Inhibitors

Start date: March 2012
Phase: Phase 4
Study type: Interventional

This is a multicenter study to evaluate the efficacy, safety and tolerability of Rivastigmine patch in patients with mild to moderate Alzheimer's disease switched from Cholinesterase Inhibitors.

NCT ID: NCT01528735 Completed - Clinical trials for Hepatitis C, Chronic

This Trial Evaluates Safety, Pharmacokinetic Profile and Anti-viral Response of BI 207127 and BI 201335 for Patients With Chronic Hepatitis C

Start date: February 2012
Phase: Phase 2
Study type: Interventional

The objective of this trial is to investigate tolerability, safety, pharmacokinetics and antiviral activity of BI 207127 NA in combination with BI 201335 NA and ribavirin for 8 weeks in Japanese treatment-naive patients with chronic GT-1 HCV infection.

NCT ID: NCT01528371 Completed - Clinical trials for Transient Hypertension

Effect of Midazolam on White-coat Hypertensive Dental Patients

Start date: October 2010
Phase: N/A
Study type: Interventional

Intravenous sedation was used for dealing with transient hypertension, so-called white-coat hypertension, before dental treatment. Midazolam used as a sedative also has antianxiety effect, and the mechanism is guessed that it minimizes patients' stress, resulting in the stability of blood pressure. The purpose of this randomized controlled trial (RCT) is to evaluate the effect of low dose of midazolam on blood pressure and anxiety scale in white-coat hypertensive dental patients.

NCT ID: NCT01528319 Completed - Clinical trials for Shoulder Dislocation

Open-Label Study for Shoulder Dislocation Using MG-1

MG-1
Start date: December 2011
Phase: N/A
Study type: Interventional

To evaluate the efficacy and safety of arthroscopic Bankart repair using MG-1 for dislocation of shoulder

NCT ID: NCT01527630 Completed - Clinical trials for Diabetes Mellitus, Type 2

Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Japanese Subjects

Start date: November 16, 2002
Phase: Phase 1
Study type: Interventional

This trial is conducted in Japan. The aim of this trial is to investigate the bioequivalence of two formulations of biphasic insulin aspart 50 (NN-X14Mix50) in healthy Japanese subjects.

NCT ID: NCT01527123 Completed - Acne Vulgaris Clinical Trials

A Study to Evaluate the Pharmacokinetics of Benzoic Acid and Hippuric Acid After Topical Administration of GSK2585823 in Japanese Subjects With Acne Vulgaris

Start date: February 28, 2012
Phase: Phase 1
Study type: Interventional

This is a Phase 1, single-center, open-label study to evaluate the pharmacokinetics of the BPO metabolites benzoic acid and hippuric acid with 7-day repeat application of GSK2585823 in subjects with acne vulgaris